Related content

Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267

By Home P.  

Diabetologia, Vol. 50, Iss. 7, 2007-07 ,pp. : 1561-1562

Springer Publishing Company

Access to resources Recommend Favorite

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

By Nauck M.   Duran S.   Kim D.   Johns D.   Northrup J.   Festa A.   Brodows R.   Trautmann M.  

Diabetologia, Vol. 50, Iss. 2, 2007-02 ,pp. : 259-267

Springer Publishing Company

Access to resources Recommend Favorite

Response to comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulphonylureas and metformin. Diabetologia 49:930–936

By Evans J.   Morris A.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1111-1111

Springer Publishing Company

Access to resources Recommend Favorite

Response to comment on: Schmidt MI, Duncan BB, Vigo A et al. (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086–2096

By Schmidt M.   Duncan B.   Vigo A.   Pankow J.   Couper D.   Ballantyne C.   Hoogeveen R.   Heiss G.  

Diabetologia, Vol. 50, Iss. 1, 2007-01 ,pp. : 237-238

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Johnson J.   Simpson S.   Eurich D.   Majumdar S.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2805-2806

Springer Publishing Company

Access to resources Recommend Favorite